case based panel discussion 2019 3.2 egfr mutation and the flaura trial, is there a difference in da
Published 4 years ago • 24 plays • Length 8:28Download video MP4
Download video MP3
Similar videos
-
7:30
case based panel discussions - egfr mutation and flaura trial - demographics, effect on treatment?
-
3:45
case based panel discussion - egfr mutation and tagrisso - progression & the role of repeat biopsy
-
8:04
case based panel discussion 3.1 egfr mutation - chemotherapy and an egfr inhibitor concurrently or s
-
4:37
case based panel discussion - egfr mutation treated with tagrisso progression while on treatment, an
-
6:00
case based panel discussions - egfr mutation & met - treatment decisions, level of met amplification
-
6:52
case based panel discussion - egfr mutation with met amplification treatment decisions and the impor
-
5:56
case based panel discussion - egfr mutation oligoprogression in brain and or body vs worsening progr
-
58:19
the implications of recent datasets for the current and future management of nsclc egfr mutations
-
5:04
case based panel discussion - egfr: oligoprogression brain &/or body vs. worsening progression
-
5:06
case based panel discussion - egfr mutation and high pdl1 - what is the role of immunotherapy in tre
-
5:18
case based panel discussion - egfr mutation -the recommended treatment for common egfr mutations
-
8:20
case based panel discussion - egfr - progression, next steps - a place for chemo & immunotherapy? v2
-
7:12
egfr mutated adenocarcinoma - case based panel discussions
-
9:12
case based panel discussion - egfr mutation patient progression and next steps
-
6:29
case based panel discussion nsclc – does a positive her2 mutation effect treatment decisions?
-
6:50
case based panel discussion 2019 3. egfr uncommon exon 20 mutation - suggested treatments targeted t
-
7:12
case based panel discussion - egfr - chemotherapy and egfr inhibitor concurrently or sequentially?
-
6:10
case based panel discussion - what is the recommended treatment for common egfr mutations